MarketCap
Facebook
X
TelegramPRA Health Sciences, Inc. Betriebsaufwand 2011-2026 | PRAH
Betriebsaufwand Jährlich PRA Health Sciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 585 M | 510 M | 484 M | 400 M | 339 M | 324 M | 351 M | - | 191 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 585 M | 191 M | 398 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.99 B | $ 120.73 | 0.28 % | $ 36.7 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 19.71 | -0.9 % | $ 212 M |  China |
 |
Aspira Women's Health
AWH
|
13.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Medpace Holdings
MEDP
|
118 M | $ 522.71 | 0.52 % | $ 15.1 B | USA |
 |
CareDx, Inc
CDNA
|
411 M | $ 17.77 | 0.77 % | $ 947 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Natera
NTRA
|
258 M | $ 211.83 | -1.31 % | $ 20.8 B | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
50.6 M | $ 1.4 | 1.45 % | $ 1.86 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 29.09 | - | $ 20 B |  Niderland |
 |
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 24.73 | 1.46 % | $ 687 M | USA |
 |
Senseonics Holdings
SENS
|
61.8 M | $ 6.85 | 1.48 % | $ 286 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
Soleno Therapeutics
SLNO
|
181 M | $ 52.6 | -0.05 % | $ 2.67 B | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 183.05 | 2.09 % | $ 9.07 B | USA |
 |
Neuronetics
STIM
|
104 M | $ 1.44 | 0.35 % | $ 95 M | USA |
 |
Interpace Biosciences
IDXG
|
20 M | $ 2.2 | - | $ 9.73 M | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 198.66 | 0.02 % | $ 142 B | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
3.69 B | $ 131.2 | 0.68 % | $ 20.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.15 B | $ 527.7 | 0.09 % | $ 199 B | USA |
 |
NeoGenomics
NEO
|
430 M | $ 8.62 | 3.23 % | $ 1.1 B | USA |
 |
Trinity Biotech plc
TRIB
|
28.3 M | $ 0.71 | -0.7 % | $ 61.9 M |  Irlanda |
 |
Fulgent Genetics
FLGT
|
181 M | $ 16.18 | 1.0 % | $ 489 M | USA |
 |
Twist Bioscience Corporation
TWST
|
116 M | $ 56.72 | -1.2 % | $ 3.39 B | USA |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | Israel |
 |
Guardant Health
GH
|
226 M | $ 85.26 | -1.32 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | Niderland |
 |
Myriad Genetics
MYGN
|
964 M | $ 5.27 | 7.23 % | $ 488 M | USA |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 2.88 | - | $ 93.5 K | USA |
 |
Biomerica
BMRA
|
5.64 M | $ 2.11 | 0.48 % | $ 4.85 M | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 114.25 | 1.05 % | $ 9.42 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 268.6 | -0.1 % | $ 22.3 B | USA |
 |
Celcuity
CELC
|
172 M | $ 120.17 | -0.56 % | $ 5.62 B | USA |
 |
Neogen Corporation
NEOG
|
1.48 B | $ 9.53 | -0.83 % | $ 2.07 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 83.04 | 0.36 % | $ 5.6 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 192.47 | -0.87 % | $ 21.4 B | USA |